NASDAQ | VICL: 0.98  -0.01
About Us

Corporate Profile

Vical researches and develops biopharmaceutical products based on our patented DNA delivery and vaccine technologies for the prevention and treatment of serious or life-threatening diseases.

Our active independent and partnered development programs include:

  • Infectious disease vaccines for use in high-risk populations
  • Infectious disease vaccines for general pediatric, adolescent and adult populations

Headquartered in San Diego, CA, Vical is independently pioneering the development of paradigm-changing DNA vaccines, and is partnering with such industry leaders as Astellas, AnGes, Bristol-Myers Squibb, Merck & Co., and Merial.


Vical's core technology involves the insertion of DNA into plasmids designed to deliver the desired genes into cells in the body. Vical's logo represents the insertion of DNA technology into a company designed to deliver gene-based products into the market.

P. 858 646 1100 10390 Pacific Center Court, San Diego, California 92121
Designed by Mentus
This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.